Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure.
Dodge SM, Hassell K, Anderson CA, Keller J, Groves B, Carroll JD. Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure. Catheter Cardiovasc Interv. 2004 Jan; 61(1):123-7.